Electric field therapy plus immunotherapy tested for tough lung cancers
NCT ID NCT06558799
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 30 times
Summary
This study tested a wearable device that sends low-intensity electric fields to tumors, combined with the immunotherapy drug pembrolizumab, in people with advanced non-small cell lung cancer that had already been treated with chemotherapy and immunotherapy. The goal was to see if this combination could help patients live longer. The study was stopped early, and only 31 people took part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AO SM Misericordia di Perugia
Perugia, 06129, Italy
-
AOUS Policlinico Le Scotte U.O.C. Immunoterapia Oncologica
Siena, 53100, Italy
-
APHP - Hôpital Ambroise-Paré
Boulogne-Billancourt, 92100, France
-
Centre Hospitalier Intercommunal de Cornouaille Service D'oncologie Médicale
Quimper, 29107, France
-
Centre Léon Berard Service D'oncologie Médicale
Lyon, 69373, France
-
Centre hospitalier intercommunal de Créteil Service de Pneumologie
Créteil, 94010, France
-
Clínica Universidad de Navarra
Pamplona, 31008, Spain
-
Clínica Universidad de Navarra, Madrid
Madrid, 28027, Spain
-
FN Motol
Prague, 150 06, Czechia
-
General University Hospital in Prague, Clinic of Oncology
Prague, 128 08, Czechia
-
Hospital Regional Universitario de Malaga (Hospital Civil)
Málaga, Spain
-
Hospital Universitario Arnau de Vilanova
Lleida, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Spain
-
Hospital Universitario del Vinalopó
Elche, 03293, Spain
-
Humanitas Gavazzeni Bergamo-U.O.Farmacia-Edificio D Piano -1
Bergamo, Italy
-
Hôpital Européen Marseille
Marseille, 13003, France
-
Hôpital Privé du Confluent Service D'oncologie Médicale
Nantes, 44277, France
-
Istituto Europeo di Oncologia
Milan, 20141, Italy
-
MS Pneumed Janusz Milanowski, Katarzyna Szmygin-Milanowska Spó?ka Jawna
Lublin, Poland
-
Montpellier University Hospital
Montpellier, 34295, France
-
Pratia MCM Kraków
Krakow, Poland
-
Rijnstate Ziekenhuis
Arnhem, Netherlands
-
Universitätsklinik f. Innere Medizin III
Salzburg, Austria
-
Vitkovicka Nemocnice
Ostrava, 1192, Czechia
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.